Evidence map›Paper›PMID 31836678›Full record

SynthesisSexually transmitted infections2020

Pregnancy and fertility-related adverse outcomes associated with

Weiming Tang, Jessica Mao, Katherine T Li, Jennifer S Walker, Roger Chou, Rong Fu, Weiying Chen, Toni Darville, Jeffrey Klausner, Joseph D Tucker

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Sexually transmitted infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 7 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 7 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Adverse pregnancy and perinatal outcomes associated withSexually transmitted infections · 2022
    Pooled it
  6. Pooled it
  7. Adverse pregnancy and neonatal outcomes associated withSexually transmitted infections · 2021
    Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. medRxiv : the preprint server for health sciences · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Antimicrobial resistance crisis in STIs: Gonorrhea andNew microbes and new infections · 2026
    Review
  17. High Burden ofMicroorganisms · 2026
    Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 5 countries.

Weiming Tang *Project-China, University of North Carolina, Guangzhou, China.ORCID 0000-0002-9026-707X
Jessica Mao *Depatment of Obstetrics and Gynecology, Johns Hopkins University, Baltimore, Maryland, USA.
Katherine T Li *Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-1201-7630
Jennifer S WalkerHealth Sciences Library, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
Roger ChouSchool of Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Rong FuDepartment of AIDS/STD Control and Prevention, Guangzhou Center for Disease Control and Prevention, Guangzhou, China.ORCID 0000-0001-9944-1436
Weiying ChenSocial Entrepreneurship to Spur Health, Guangzhou, Guangdong, China.
Toni DarvillePediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
Jeffrey KlausnerMedicine, University of California, Los Angeles, San Francisco, California, USA.
Joseph D TuckerUNC Project-China, Guangzhou, Guangdong, China jdtucker@med.unc.edu.ORCID 0000-0003-2804-1181
University of North Carolina at Chapel Hill · USCentre for Chronic Disease Control · INGuangdong Provincial Center for Disease Control and Prevention · CNGuangzhou Center for Disease Control and Prevention · CNJinan University · CNJohns Hopkins University · USMassachusetts General Hospital · USOregon Health & Science University · USUniversity of California, Los Angeles · US

Funding

Spurring Innovation in HIV Testing and Linkage: A Crowdsourcing Approach -Diversity SupplementR01AI114310 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TUCKER, JOSEPH DAVID, WEI, CHONGYI · 2014 to 2018
$3.3M
Mentoring Multidisciplinary Global HIV Patient-Oriented ResearchK24AI143471 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph David Tucker · 2019 to 2026
$1.4M
Enhancing Partner Services among Men Who Have Sex with Men Living With HIV: A Pilot Randomized Controlled TrialR34MH119963 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TANG, WEIMING, TUCKER, JOSEPH DAVID · 2019 to 2021
$568k
NIAID NIH HHS K24 AI143471NIAID NIH HHS R01 AI114310NIMH NIH HHS R34 MH119963
6 · The paper itself

Abstract

backgroundGenital chlamydia infection in women is often asymptomatic, but may result in adverse outcomes before and during pregnancy. The purpose of this study was to examine the strength of the relationships between chlamydia infection and different reproductive health outcomes and to assess the certainty of the evidence.

methodsThis review was registered and followed the Cochrane guidelines. We searched three databases to quantitatively examine adverse outcomes associated with chlamydia infection. We included pregnancy and fertility-related outcomes. We performed meta-analyses on different study designs for various adverse outcomes using unadjusted and adjusted analyses.

resultsWe identified 4730 unique citations and included 107 studies reporting 12 pregnancy and fertility-related outcomes. Sixty-eight studies were conducted in high-income countries, 37 studies were conducted in low-income or middle-income countries, and 2 studies were conducted in both high-income and low-income countries. Chlamydia infection was positively associated with almost all of the 12 included pregnancy and fertility-related adverse outcomes in unadjusted analyses, including stillbirth (OR=5.05, 95% CI 2.95 to 8.65 for case-control studies and risk ratio=1.28, 95% CI 1.09 to 1.51 for cohort studies) and spontaneous abortion (OR=1.30, 95% CI 1.14 to 1.49 for case-control studies and risk ratio=1.47, 95% CI 1.16 to 1.85 for cohort studies). However, there were biases in the design and conduct of individual studies, affecting the certainty of the overall body of evidence. The risk of adverse outcomes associated with chlamydia is higher in low-income and middle-income countries compared with high-income countries.

conclusionChlamydia is associated with an increased risk of several pregnancy and fertility-related adverse outcomes in unadjusted analyses, especially in low-income and middle-income countries. Further research on how to prevent the sequelae of chlamydia in pregnant women is needed. TRIAL REGISTRATION NUMBER: CRD42017056818.

Indexed as

Abortion, SpontaneousChlamydia InfectionsChlamydia trachomatisEndometritisFemaleHumansInfant, Low Birth WeightInfant, NewbornInfant, Small for Gestational AgeInfertility, FemaleObstetric Labor, PrematurePre-EclampsiaPregnancyPregnancy Complications, InfectiousPregnancy, EctopicPregnancy Outcomechlamydia trachomatisinfertilitymeta-analysispregnancywomen

Identifiers

PMID31836678
PMCPMC7292777
OpenAlexW2996200789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.